ENST00000451493.5:c.-202G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000451493.5(SPART):​c.-202G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 152,386 control chromosomes in the GnomAD database, including 5,246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5228 hom., cov: 32)
Exomes 𝑓: 0.40 ( 18 hom. )

Consequence

SPART
ENST00000451493.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.150

Publications

6 publications found
Variant links:
Genes affected
SPART (HGNC:18514): (spartin) This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008]
SPART-AS1 (HGNC:39933): (SPART antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 13-36346781-C-G is Benign according to our data. Variant chr13-36346781-C-G is described in ClinVar as Benign. ClinVar VariationId is 1526321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000451493.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPART
NM_001142294.2
c.-2-10949G>C
intron
N/ANP_001135766.1Q8N0X7
SPART-AS1
NR_045180.1
n.77+274C>G
intron
N/A
SPART-AS1
NR_045181.1
n.77+274C>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPART
ENST00000451493.5
TSL:1
c.-202G>C
5_prime_UTR
Exon 1 of 9ENSP00000414147.1Q8N0X7
SPART
ENST00000355182.8
TSL:5
c.-2-10949G>C
intron
N/AENSP00000347314.4Q8N0X7
SPART
ENST00000650221.1
c.-2-10949G>C
intron
N/AENSP00000497209.1Q8N0X7

Frequencies

GnomAD3 genomes
AF:
0.248
AC:
37763
AN:
152066
Hom.:
5232
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.297
Gnomad ASJ
AF:
0.223
Gnomad EAS
AF:
0.514
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.234
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.284
Gnomad OTH
AF:
0.222
GnomAD4 exome
AF:
0.401
AC:
81
AN:
202
Hom.:
18
Cov.:
0
AF XY:
0.375
AC XY:
57
AN XY:
152
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.417
AC:
5
AN:
12
South Asian (SAS)
AF:
1.00
AC:
2
AN:
2
European-Finnish (FIN)
AF:
0.750
AC:
3
AN:
4
Middle Eastern (MID)
AF:
0.500
AC:
2
AN:
4
European-Non Finnish (NFE)
AF:
0.395
AC:
64
AN:
162
Other (OTH)
AF:
0.333
AC:
4
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.559
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.248
AC:
37775
AN:
152184
Hom.:
5228
Cov.:
32
AF XY:
0.250
AC XY:
18618
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.141
AC:
5845
AN:
41550
American (AMR)
AF:
0.298
AC:
4555
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.223
AC:
773
AN:
3472
East Asian (EAS)
AF:
0.512
AC:
2637
AN:
5150
South Asian (SAS)
AF:
0.288
AC:
1391
AN:
4830
European-Finnish (FIN)
AF:
0.234
AC:
2476
AN:
10596
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.284
AC:
19284
AN:
67984
Other (OTH)
AF:
0.225
AC:
473
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1463
2925
4388
5850
7313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.252
Hom.:
651
Bravo
AF:
0.247
Asia WGS
AF:
0.402
AC:
1399
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
6.8
DANN
Benign
0.67
PhyloP100
-0.15
PromoterAI
-0.31
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9531842; hg19: chr13-36920918; API